Cargando…

TREM1 predicts response to anti-tumor necrosis factor in inflammatory bowel diseases: Towards precision medicine

Detalles Bibliográficos
Autores principales:	Felice, Carla, Pugliese, Daniela, Guidi, Luisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443576/ https://www.ncbi.nlm.nih.gov/pubmed/30808577 http://dx.doi.org/10.1016/j.ebiom.2019.02.045

Ejemplares similares

Update on the management of inflammatory bowel disease: specific role of adalimumab
por: Guidi, Luisa, et al.
Publicado: (2011)

Susceptibility gene profiling elucidates the pathogenesis of inflammatory bowel disease and provides precision medicine
por: Gao, Han, et al.
Publicado: (2023)

FOXP3(+) T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFα Agents
por: Guidi, Luisa, et al.
Publicado: (2013)

Toward a precision medicine approach for autoimmunity
por: Kissler, Stephan
Publicado: (2022)

Anti-tumor necrosis factor therapy in inflammatory bowel disease
por: Ramakrishna, B.S.
Publicado: (2017)

Circular RNA in liquid biopsy as biomarkers toward precision medicine
por: Lee, Yueh-Chun, et al.
Publicado: (2023)

Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Precision Medicine in Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2021)

Precision Medicine in Inflammatory Bowel Disease
por: Annese, Vito, et al.
Publicado: (2023)

Tumor necrosis factor-α blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?
por: Van den Bosch, Filip, et al.
Publicado: (2005)

Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease
por: Verstockt, Bram, et al.
Publicado: (2019)

4 Ds in health research—working together toward rapid precision medicine
por: Niederberger, Ellen, et al.
Publicado: (2019)

Immunotherapy in cervical cancer: the advent of precision medicine
por: De Felice, Francesca, et al.
Publicado: (2020)

TREM Receptors Connecting Bowel Inflammation to Neurodegenerative Disorders
por: Natale, Gianfranco, et al.
Publicado: (2019)

Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
por: Scheinberg, Morton, et al.
Publicado: (2014)

Data‐driven prediction of biologic treatment responses in psoriasis: steps towards precision medicine
por: van der Schoot, L. S., et al.
Publicado: (2021)

Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
por: Billmeier, Ulrike, et al.
Publicado: (2016)

Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor
por: Pagnini, Cristiano, et al.
Publicado: (2019)

Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
por: Park, Jihye, et al.
Publicado: (2021)

Exit strategies in inflammatory bowel disease: Looking beyond anti-tumor necrosis factors
por: Crispino, Federica, et al.
Publicado: (2023)

Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis
por: Alivernini, Stefano, et al.
Publicado: (2018)

Precision Medicine: The new era in medicine
por: Twilt, Marinka
Publicado: (2016)

Monocyte TREM-1 membrane expression in non-infectious inflammation
por: Cavaillon, Jean-Marc
Publicado: (2009)

Insights from new in vivo models of TREM2 variants
por: Jain, Nimansha, et al.
Publicado: (2023)

The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis
por: Genua, Marco, et al.
Publicado: (2014)

Why rare disease needs precision medicine—and precision medicine needs rare disease
por: Might, Matthew, et al.
Publicado: (2022)

TREM2 and microglia exosomes: a potential highway for pathological tau
por: Jain, Nimansha, et al.
Publicado: (2022)

Surplus Ceramides: An Added Twist in the Tale of TREM2 and Insulin Resistance
por: Webster, Kierstin L., et al.
Publicado: (2021)

Capturing phenotypes for precision medicine
por: Robinson, Peter N., et al.
Publicado: (2015)

‘En route’ to precision medicine
por: Hijnen, D.J.
Publicado: (2019)

Experimental pharmacology in precision medicine
por: Urbaniak, Alicja, et al.
Publicado: (2023)

Fatal infections in older patients with inflammatory bowel disease on anti-tumor necrosis factor therapy
por: Lee, Way-Seah, et al.
Publicado: (2017)

Association of Anti–Tumor Necrosis Factor Therapy With Mortality Among Veterans With Inflammatory Bowel Disease
por: Cohen-Mekelburg, Shirley, et al.
Publicado: (2021)

Translational research identifies a metabolism pathway involved in first-episode of schizophrenia: Towards precision medicine
por: Simonneau, Michel
Publicado: (2019)

Study of tumor necrosis factor receptor in the inflammatory bowel disease
por: Souza, Roberta Figueiroa, et al.
Publicado: (2023)

Toward precision medicine in inflammatory breast cancer
por: Viale, Giulia, et al.
Publicado: (2019)

Systems biology in inflammatory bowel diseases: on the way to precision medicine
por: Dovrolis, Nikolas, et al.
Publicado: (2019)

Precision medicine in inflammatory bowel disease: concept, progress and challenges
por: Borg-Bartolo, Simon P., et al.
Publicado: (2020)

Integration and implementation of precision medicine in the multifaceted inflammatory bowel disease
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r460ptk7odjcri7j6gmseiaiof